浙江中西医结合杂志
浙江中西醫結閤雜誌
절강중서의결합잡지
ZHEJIANG JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
10期
862-864,870
,共4页
沈双%卢振产%胡正刚%王亚仙
瀋雙%盧振產%鬍正剛%王亞仙
침쌍%로진산%호정강%왕아선
PPARγ基因%进展性脑梗死%单核苷酸多态性
PPARγ基因%進展性腦梗死%單覈苷痠多態性
PPARγ기인%진전성뇌경사%단핵감산다태성
PPARγgene%progressive ischemic stroke%single nucleotide polymorphism
目的:探讨PPARγC161T基因多态性及其表达与进展性脑梗死的关系。方法进展性脑梗死患者225例纳入进展组,同期住院的非进展性脑梗死患者225例为非进展组。应用多聚酶链-限制性片段长度多态性(PCR-RFLP)技术检测两组PPARγ基因C161T的基因型,酶联免疫吸附(ELISA)法检测PPARγ基因表达水平。结果进展组和非进展组患者PPARγ C161T基因多态性频率无明显差异(P>0.05)。入院时、入院后72h以及发病后4周,携带C等位基因脑梗死患者的PPARγ表达量均低于携带T基因的脑梗死患者(P<0.01),并且在携带C等位基因患者中进展组PPARγ表达量低于非进展组(P<0.01)。与入院时比较,入院后72h以及发病后4周各基因型的PPARγ表达量明显升高(P<0.01)。结论 PPARγC161T基因多态性的表达可能与进展性脑梗死的发生有关。
目的:探討PPARγC161T基因多態性及其錶達與進展性腦梗死的關繫。方法進展性腦梗死患者225例納入進展組,同期住院的非進展性腦梗死患者225例為非進展組。應用多聚酶鏈-限製性片段長度多態性(PCR-RFLP)技術檢測兩組PPARγ基因C161T的基因型,酶聯免疫吸附(ELISA)法檢測PPARγ基因錶達水平。結果進展組和非進展組患者PPARγ C161T基因多態性頻率無明顯差異(P>0.05)。入院時、入院後72h以及髮病後4週,攜帶C等位基因腦梗死患者的PPARγ錶達量均低于攜帶T基因的腦梗死患者(P<0.01),併且在攜帶C等位基因患者中進展組PPARγ錶達量低于非進展組(P<0.01)。與入院時比較,入院後72h以及髮病後4週各基因型的PPARγ錶達量明顯升高(P<0.01)。結論 PPARγC161T基因多態性的錶達可能與進展性腦梗死的髮生有關。
목적:탐토PPARγC161T기인다태성급기표체여진전성뇌경사적관계。방법진전성뇌경사환자225례납입진전조,동기주원적비진전성뇌경사환자225례위비진전조。응용다취매련-한제성편단장도다태성(PCR-RFLP)기술검측량조PPARγ기인C161T적기인형,매련면역흡부(ELISA)법검측PPARγ기인표체수평。결과진전조화비진전조환자PPARγ C161T기인다태성빈솔무명현차이(P>0.05)。입원시、입원후72h이급발병후4주,휴대C등위기인뇌경사환자적PPARγ표체량균저우휴대T기인적뇌경사환자(P<0.01),병차재휴대C등위기인환자중진전조PPARγ표체량저우비진전조(P<0.01)。여입원시비교,입원후72h이급발병후4주각기인형적PPARγ표체량명현승고(P<0.01)。결론 PPARγC161T기인다태성적표체가능여진전성뇌경사적발생유관。
Objective To investigate the relationship between C161T polymorphism on peroxisome proliferator-activated receptor gamma(PPARγ) gene and progressive ischemic stroke. Methods The C161T variants on PPARγgene of 225 patients with progressive ischemic stroke and 225 non-progressive ischemic stroke patients matched with age, gender, and past history of disease was examined by using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). The serum PPARγ was measured by ELISA. Results No statistical differences in frequencies of genotype and allele was noted between the progressive and non-progressive ischemic stroke pa-tients (P>0.05). At admission, 72h after admission and 4 weeks after onset, the C allele carriers had lower levels of PPARγ, compared with the T allele carriers (P<0.01). In C allele carriers, the PPARγ expression in progressive ischemic stroke patients was significantly lower than that in non-progressive patients(P<0.01). Compared with base-line, the PPARγ expression significantly increased in each genotype at 72h after admission and 4 weeks after onset (P<0.01). Conclusion The C161T polymorphism on PPARγ gene may be related to onset of progressive ischemic stroke.